{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:21:15Z","timestamp":1794367275709,"version":"4.9.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate outcomes of phacoemulsification plus Tanito microhook (TMH) trabeculotomy and assess differences by incision extent, glaucoma severity, and baseline medications classes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective cohort of 880 open-angle glaucoma eyes (119 exfoliation glaucoma, 761 primary open-angle glaucoma) undergoing phaco-TMH. Success was defined using the American Academy of Ophthalmology (AAO) minimally invasive glaucoma surgery (MIGS) endpoint for cataract-combined procedures (\u2009\u2265\u20091 medication reduction without intraocular pressure [IOP] increase, or \u226520% IOP reduction to \u226421\u2009mmHg) with no additional glaucoma surgery, hypotony, or loss of light perception. Prespecified alternative IOP-defined success definitions were also evaluated. Outcomes were stratified by incision extent (\u2009&lt;\u20096 and \u22656 clock hours), baseline glaucoma severity (early, moderate, advanced), and baseline medications classes (0\u20131, 2, \u22653). Time-to-failure was evaluated using Kaplan-Meier analysis and multivariable Cox proportional hazards models adjusted for surgical year and baseline covariates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Mean (SD) IOP decreased from 17.2 (4.9) mmHg at baseline to 13.1 (3.5) at 12 months and 13.1 (3.9) at 24 months, and medications decreased from 2.6 (1.3) to 2.0 (1.3) at 12 and 24 months. Two-year cumulative success was 59.0% (95% CI, 54.4 to 63.2) by AAO MIGS criteria. In the multivariable Cox model, \u22656 clock hours was not significantly associated with surgical failure compared with &lt;6 clock hours (adjusted HR, 1.14; 95% CI, 0.85 to 1.53;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.367). Higher baseline medication burden was associated with worse success across IOP-defined criteria.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients undergoing phacoemulsification combined with TMH trabeculotomy, IOP and medication burden improved through 2 years. Surgical success did not differ by incision extent or baseline glaucoma severity, whereas higher baseline medication burden was associated with worse IOP-defined success.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41433-026-04749-x","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:53:27Z","timestamp":1784699607000},"page":"2417-2423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes of phacoemulsification combined with ab interno trabeculotomy: stratified by incision extent, glaucoma severity, and baseline number of medications"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8312-6623","authenticated-orcid":false,"given":"Takashi","family":"Nishida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5464-2573","authenticated-orcid":false,"given":"Takuhei","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Tanito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"4749_CR1","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ophtha.2023.10.009","volume":"131","author":"GM Richter","year":"2024","unstructured":"Richter GM, Takusagawa HL, Sit AJ, Rosdahl JA, Chopra V, Ou Y, et al. Trabecular procedures combined with cataract surgery for open-angle glaucoma: a report by the American Academy of ophthalmology. Ophthalmology. 2024;131:370\u201382.","journal-title":"Ophthalmology"},{"key":"4749_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/ICU.0b013e32834ff1e7","volume":"23","author":"H Saheb","year":"2012","unstructured":"Saheb H, Ahmed II. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012;23:96\u2013104.","journal-title":"Curr Opin Ophthalmol"},{"key":"4749_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/ICU.0000000000000731","volume":"32","author":"K Vinod","year":"2021","unstructured":"Vinod K, Gedde SJ. Safety profile of minimally invasive glaucoma surgery. Curr Opin Ophthalmol. 2021;32:160\u20138.","journal-title":"Curr Opin Ophthalmol"},{"key":"4749_CR4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1001\/jamaophthalmol.2021.2351","volume":"139","author":"AK Bicket","year":"2021","unstructured":"Bicket AK, Le JT, Azuara-Blanco A, Gazzard G, Wormald R, Bunce C, et al. Minimally invasive glaucoma surgical techniques for open-angle glaucoma: an overview of cochrane systematic reviews and network meta-analysis. JAMA Ophthalmol. 2021;139:983\u20139.","journal-title":"JAMA Ophthalmol"},{"key":"4749_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ophtha.2024.07.030","volume":"132","author":"SJ Gedde","year":"2025","unstructured":"Gedde SJ, Vinod K, Bowden EC, Kolomeyer NN, Chopra V, Challa P, et al. Special commentary: reporting clinical endpoints in studies of minimally invasive glaucoma surgery. Ophthalmology. 2025;132:141\u201353.","journal-title":"Ophthalmology"},{"key":"4749_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ogla.2018.06.006","volume":"1","author":"EG Sieck","year":"2018","unstructured":"Sieck EG, Epstein RS, Kennedy JB, SooHoo JR, Pantcheva MB, Patnaik JL, et al. Outcomes of kahook dual blade goniotomy with and without phacoemulsification cataract extraction. Ophthalmol Glaucoma. 2018;1:75\u201381.","journal-title":"Ophthalmol Glaucoma"},{"key":"4749_CR7","doi-asserted-by":"crossref","unstructured":"Rabin RL, Han JC, Rhee DJ. Ab-interno trabeculotomy. In: Sng CCA, Barton K. (eds). Minimally Invasive Glaucoma Surgery. Springer Singapore: Singapore; 2021. pp 41\u201357.","DOI":"10.1007\/978-981-15-5632-6_4"},{"key":"4749_CR8","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1136\/bjophthalmol-2020-316624","volume":"105","author":"T Sato","year":"2021","unstructured":"Sato T, Kawaji T. 12-month randomised trial of 360 degrees and 180 degrees Schlemm\u2019s canal incisions in suture trabeculotomy ab interno for open-angle glaucoma. Br J Ophthalmol. 2021;105:1094\u20138.","journal-title":"Br J Ophthalmol"},{"key":"4749_CR9","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.2147\/OPTH.S362932","volume":"16","author":"MJ Gallardo","year":"2022","unstructured":"Gallardo MJ, Pyfer MF, Vold SD, Sarkisian SR Jr, Campbell A, Singh IP, et al. Canaloplasty and trabeculotomy combined with phacoemulsification for glaucoma: 12-month results of the GEMINI study. Clin Ophthalmol. 2022;16:1225\u201334.","journal-title":"Clin Ophthalmol"},{"key":"4749_CR10","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1111\/aos.12888","volume":"94","author":"M Tanito","year":"2016","unstructured":"Tanito M, Sano I, Ikeda Y, Fujihara E. Microhook ab interno trabeculotomy, a novel minimally invasive glaucoma surgery, in eyes with open-angle glaucoma with scleral thinning. Acta Ophthalmol. 2016;94:e371\u2013372.","journal-title":"Acta Ophthalmol"},{"key":"4749_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/OPTH.S152406","volume":"12","author":"M Tanito","year":"2018","unstructured":"Tanito M. Microhook ab interno trabeculotomy, a novel minimally invasive glaucoma surgery. Clin Ophthalmol. 2018;12:43\u201348.","journal-title":"Clin Ophthalmol"},{"key":"4749_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ogla.2021.11.005","volume":"5","author":"S Mori","year":"2022","unstructured":"Mori S, Tanito M, Shoji N, Yokoyama Y, Kameda T, Shoji T, et al. Noninferiority of microhook to trabectome: trabectome versus ab interno microhook trabeculotomy comparative study (tram trac study). Ophthalmol Glaucoma. 2022;5:452\u201361.","journal-title":"Ophthalmol Glaucoma"},{"key":"4749_CR13","doi-asserted-by":"crossref","unstructured":"Tanito M, Sugihara K, Tsutsui A, Hara K, Manabe K, Matsuoka Y. Midterm results of microhook ab interno trabeculotomy in initial 560 eyes with glaucoma. J Clin Med. 2021;10.","DOI":"10.3390\/jcm10040814"},{"key":"4749_CR14","doi-asserted-by":"crossref","unstructured":"Takayanagi Y, Ichioka S, Ishida A, Tsutsui A, Tanito M. Fellow-eye comparison between phaco-microhook ab-interno trabeculotomy and phaco-iStent trabecular micro-bypass stent. J Clin Med. 2021;10.","DOI":"10.3390\/jcm10102129"},{"key":"4749_CR15","doi-asserted-by":"crossref","unstructured":"Maheshwari D, Pillai MR, Grover DS, Nagdev NG, Gupta S, Uduman MS et al. Two-year outcomes of combined phacoemulsification and ab interno tanito microhook trabeculotomy in open-angle glaucoma: a prospective randomized trial. Ophthalmol Glaucoma 2025.","DOI":"10.1016\/j.ogla.2025.12.004"},{"key":"4749_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ophtha.2010.07.007","volume":"118","author":"TW Samuelson","year":"2011","unstructured":"Samuelson TW, Katz LJ, Wells JM, Duh YJ, Giamporcaro JE. Group USiS. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118:459\u201367.","journal-title":"Ophthalmology"},{"key":"4749_CR17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ophtha.2019.03.006","volume":"126","author":"TW Samuelson","year":"2019","unstructured":"Samuelson TW, Sarkisian SR Jr, Lubeck DM, Stiles MC, Duh YJ, Romo EA, et al. Prospective, randomized, controlled pivotal trial of an ab interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results. Ophthalmology. 2019;126:811\u201321.","journal-title":"Ophthalmology"},{"key":"4749_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ophtha.2018.05.012","volume":"126","author":"TW Samuelson","year":"2019","unstructured":"Samuelson TW, Chang DF, Marquis R, Flowers B, Lim KS, Ahmed IIK, et al. A schlemm canal microstent for intraocular pressure reduction in primary open-angle glaucoma and cataract: the HORIZON study. Ophthalmology. 2019;126:29\u201337.","journal-title":"Ophthalmology"},{"key":"4749_CR19","first-page":"189","volume":"10","author":"GM Richter","year":"2016","unstructured":"Richter GM, Coleman AL. Minimally invasive glaucoma surgery: current status and future prospects. Clin Ophthalmol. 2016;10:189\u2013206.","journal-title":"Clin Ophthalmol"},{"key":"4749_CR20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.exer.2005.10.011","volume":"82","author":"M Johnson","year":"2006","unstructured":"Johnson M. \u2018What controls aqueous humour outflow resistance?\u2019. Exp Eye Res. 2006;82:545\u201357.","journal-title":"Exp Eye Res"},{"key":"4749_CR21","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.jcrs.2014.06.020","volume":"40","author":"SS Swaminathan","year":"2014","unstructured":"Swaminathan SS, Oh DJ, Kang MH, Rhee DJ. Aqueous outflow: segmental and distal flow. J Cataract Refract Surg. 2014;40:1263\u201372.","journal-title":"J Cataract Refract Surg"},{"key":"4749_CR22","doi-asserted-by":"crossref","unstructured":"Sugihara K, Shimada A, Ichioka S, Harano A, Tanito M. Comparison of phaco-tanito microhook trabeculotomy between propensity-score-matched 120-degree and 240-degree incision groups. J Clin Med. 2023;12.","DOI":"10.3390\/jcm12237460"},{"key":"4749_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-025-04348-6","volume":"25","author":"R Matlov Kormas","year":"2025","unstructured":"Matlov Kormas R, Gafni Klepfish E, Marcovich A, Kassem R. Efficacy and safety of 360\u00ba and 180\u00ba gonioscopy-assisted transluminal trabeculotomy in combination with phacoemulsification in patients with open-angle glaucoma: a retrospective case-control study. BMC Ophthalmol. 2025;25:656.","journal-title":"BMC Ophthalmol"},{"key":"4749_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/IJG.0000000000002391","volume":"33","author":"M Gunay","year":"2024","unstructured":"Gunay M, Cigiltepe IB, Turk A, Uzlu D, Kose B. A prospective comparison of 180 versus 360-degree gonioscopy-assisted transluminal trabeculotomy outcomes in pseudoexfoliation glaucoma. J Glaucoma. 2024;33:559\u201365.","journal-title":"J Glaucoma"},{"key":"4749_CR25","doi-asserted-by":"publisher","first-page":"P71","DOI":"10.1016\/j.ophtha.2020.10.022","volume":"128","author":"SJ Gedde","year":"2021","unstructured":"Gedde SJ, Vinod K, Wright MM, Muir KW, Lind JT, Chen PP, et al. Primary open-angle glaucoma preferred practice pattern(R). Ophthalmology. 2021;128:P71\u2013P150.","journal-title":"Ophthalmology"},{"key":"4749_CR26","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1038\/s41433-022-02196-y","volume":"37","author":"GE Bravetti","year":"2023","unstructured":"Bravetti GE, Gillmann K, Salinas L, Berdahl JP, Lazcano-Gomez GS, Williamson BK, et al. Surgical outcomes of excisional goniotomy using the kahook dual blade in severe and refractory glaucoma: 12-month results. Eye (Lond). 2023;37:1608\u201313.","journal-title":"Eye (Lond)"},{"key":"4749_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ajo.2024.02.033","volume":"264","author":"L Magacho","year":"2024","unstructured":"Magacho L, Franco C, Akio IE, Pereira ACA, Teno B, Lucena-Neto F, et al. Gonioscopy-assisted transluminal trabeculotomy outcomes under different levels of glaucoma severity: a multicenter, comparative study. Am J Ophthalmol. 2024;264:75\u201384.","journal-title":"Am J Ophthalmol"},{"key":"4749_CR28","doi-asserted-by":"publisher","first-page":"e0151926","DOI":"10.1371\/journal.pone.0151926","volume":"11","author":"RT Loewen","year":"2016","unstructured":"Loewen RT, Roy P, Parikh HA, Dang Y, Schuman JS, Loewen NA. Impact of a glaucoma severity index on results of trabectome surgery: larger pressure reduction in more severe glaucoma. PLoS One. 2016;11:e0151926.","journal-title":"PLoS One"},{"key":"4749_CR29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ophtha.2022.10.021","volume":"130","author":"SA Yang","year":"2023","unstructured":"Yang SA, Ciociola EC, Mitchell W, Hall N, Lorch AC, Miller JW, et al. Effectiveness of microinvasive glaucoma surgery in the united states: intelligent research in sight registry analysis 2013\u20132019. Ophthalmology. 2023;130:242\u201355.","journal-title":"Ophthalmology"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04749-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:55:35Z","timestamp":1792173335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04749-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":29,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4749"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04749-x","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"11 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"TN is a consultant of Topcon. TS reported patents and financial support from Inami & Co., Ltd. (co-developer of the TMH Shoji edition; receives royalties). MT reported patents and financial support from Inami & Co., Ltd. (co-developer of the original TMH; receives royalties). The company had no role in study design, data collection, analysis, manuscript preparation, or decision to publish.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}